Abstract:IMPORTANCE It remains unclear whether cystatin C and cystatin Cbased kidney function measures are associated with frailty trajectories and physical function decline. OBJECTIVE To examine the associations of cystatin C level, cystatin C estimated glomerular filtration rate (eGFRcys), and the difference between eGFRs (eGFRdiff) using cystatin C and creatinine levels with long-term deficit-accumulation frailty trajectories and physical function decline. DESIGN, SETTING, AND PARTICIPANTS This prospective cohort study used data from 15 949 participants in the China Health and Retirement Longitudinal Study (CHARLS) and the US Health and Retirement Study (HRS), 2 ongoing nationally representative cohort studies enrolling community-dwelling older people. Biennial surveys, known as waves, are conducted in both the CHARLS and the HRS. Seven-year data from wave 1 (May 2011 to March 2012) to wave 4 (July to September 2018) in the CHARLS and 12-year data from wave 8 (March 2006 to February 2007) to wave 14 (April 2018 to June 2019) in the HRS were assessed, with wave 1 in the CHARLS and wave 8 in the HRS serving as baseline waves. Data were analyzed from February 12 to May 20, 2022. EXPOSURES Baseline serum cystatin C and creatinine levels. Cystatin C eGFR and creatinine estimated GFR (eGFRcr) were calculated using the 2021 race-free equations developed by the Chronic Kidney Disease Epidemiology Collaboration. The difference between eGFRcys and eGFRcr was calculated by subtracting eGFRcr from eGFRcys. MAIN OUTCOMES AND MEASURES Based on 12-year follow-up data from the HRS and 7-year follow-up data from the CHARLS, a 29-item deficit-accumulation frailty index (FI) was constructed to assess frailty trajectories at each visit. Physical function decline was evaluated using repeated objective physical function measurements (grip strength and gait speed). Linear mixed models were used to examine longitudinal associations. RESULTS Among 15 949 older adults included in the analysis, 9114 participants were from the HRS (mean [SD] age, 66.2 [10.1] years; 5244 women [57.5%]), and 6835 were from the CHARLS (mean [SD] age, 58.4 [9.8] years; 3477 women [50.9%]). With regard to race and ethnicity, the HRS cohort included 7755 White individuals (85.1%) and 1359 individuals (14.9%) of other races and/or ethnicities (including American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Pacific Islander, and other); all participants in the CHARLS cohort were of Chinese ethnicity. Each SD increment in serum cystatin C was associated with a faster increase in FI in both the HRS cohort (beta = 0.050 SD/y; 95% CI, 0.045-0.055 SD/y; P = .001) and the CHARLS cohort (beta = 0.051 SD/y; 95% CI, 0.042-0.060 SD/y; P = .001). An inverse association was observed for eGFRCys (HRS cohort: beta = -0.058 SD/y; 95% CI, -0.062 to -0.053 SD/y; P = .001; CHARLS cohort: beta = -0.056 SD/y; 95% CI, -0.064 to -0.047 SD/y; P = .001). These associations remained after controlling for serum creatinine (beta = 0.051 SD/y; 95% CI, 0.042-0.060 SD/y; P = .001) and eGFRcr (beta = -0.056 SD/y; 95% CI, -0.064 to -0.047 SD/y; P = .001) in the CHARLS cohort. Similar to the results observed for eGFRcys, each SD increment in the eGFRdiff was associated with a slower increase in FI (beta = -0.027 SD/y; 95% CI, -0.035 to -0.018 SD/y; P = .001) in the CHARLS cohort. Similar findings were observed for physical function decline. For example, each SD increment in serum cystatin C was associated with faster decreases in both grip strength (beta = -0.006 SD/y; 95% CI, -0.008 to -0.003 SD/y; P = .001) and gait speed (beta = -0.007 SD/y; 95% CI, -0.011 to -0.003 SD/y; P = .001) in the HRS cohort and faster decreases in gait speed (beta = -0.017 SD/y; 95% CI, -0.027 to -0.006 SD/y; P = .002) in the CHARLS cohort. CONCLUSIONS AND RELEVANCE In this cohort study, cystatin C, eGFRcys, and eGFRdiff were associated with long-term frailty trajectories and physical function decline among community-dwelling older people without frailty. Monitoring kidney function using cystatin C could have clinical utility in identifying the risk of accelerated frailty progression.

Sex differences in the relationship of intraindividual difference in estimated glomerular filtration rate by cystatin C and creatinine and depressive symptoms among middle-aged and older adults in China

Sex Differences in the Relationship of Serum Creatinine to Cystatin C Ratio and Depressive Symptoms among Middle-Aged and Older Adults in China

Association of renal function and depressive symptoms: Evidence from the China health and retirement longitudinal study

Body Mass Index, Waist Circumference and Waist–hip Ratio Are Associated with Depressive Symptoms in Older Chinese Women: Results from the Rugao Longevity and Ageing Study (Rulas)

Association between early life circumstances and depressive symptoms among Chinese older adults: Results from China health and retirement longitudinal study Early life circumstances and depression

Reduced estimated glomerular filtration rate is associated with depressive symptoms in elder Chinese: a population-based cross-sectional study.

Sex-specific in the association between depressive symptoms and risk of cognitive impairment in Chinese older adults

Association Between Depression and Renal Hyperfiltration in a General Chinese Population

Age and estimated glomerular filtration rate in Chinese older adults: a cohort study from 2014 to 2020

Sex difference in the association between creatinine-to-cystatin C ratio and metabolic syndrome among Chinese adults

Association Between Serum Cystatin C and Cognitive Decline Independently from Creatinine: Evidence from Two Nationally Representative Aging Cohorts.

Association of depressive symptoms and incident chronic kidney disease in middle-aged and older adults

Changes in gender disparities of depressive symptoms among middle-aged and older adults in China: an age-period-cohort analysis

Sex Differences in the Association Between Serum Lipids and Depressive Symptoms: A Longitudinal Population-Based Study

No association between C-reactive protein and depressive symptoms among the middle-aged and elderly in China: Evidence from the China Health and Retirement Longitudinal Study.

Association of estimated cardiorespiratory fitness in middle-aged and elderly people with cardiovascular disease: Evidence from the China health and retirement longitudinal study

The critical role of physical frailty and function on depressive symptoms among community-dwelling older adults in China: A cross-sectional study

Diabetes mellitus: association of cystatin C versus creatinine-based estimated glomerular filtration rate with mortality and cardiovascular events

Gender differences in age-related decline in glomerular filtration rates in healthy people and chronic kidney disease patients

The relationship between the joint effect of C-reactive protein and glycated hemoglobin with the risk of depressive symptoms among middle-aged and older adults: Findings from the China health and retirement longitudinal study

Association of Cystatin C Kidney Function Measures with Long-term Deficit-Accumulation Frailty Trajectories and Physical Function Decline